Anti-Lung Cancer Compound Library

Ref. TM-L2190

Informations sur le produit

• Nom: Anti-Lung Cancer Compound Library

Description

A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；
- Targets include EGFR, PI3K, FGFR, HER2, ALK, c-Met, etc.；
- Some compounds have been in market or in clinical trials;
- Detailed compound information with structure, target, and biological activity description；
- NMR and HPLC validated to ensure high purity and quality.

• Marque: Targetmol